<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02349438</url>
  </required_header>
  <id_info>
    <org_study_id>CR-5685</org_study_id>
    <nct_id>NCT02349438</nct_id>
  </id_info>
  <brief_title>Assessment of Contact Lens Wettability Using Wavefront Aberrometry</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the feasibility that differences in contact lens wettability can be
      measured with a wavefront sensor.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Natural Blinking</measure>
    <time_frame>2 hours post insertion</time_frame>
    <description>Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with natural blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Controlled Blink</measure>
    <time_frame>2 hours post insertion</time_frame>
    <description>Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Higher Order Root Mean Square (HO RMS) - Distance Target in Primary Gaze With Controlled Blink</measure>
    <time_frame>2 hours post insertion</time_frame>
    <description>Wavefront metric measured by COAS wavefront sensor while subject fixates a distant target in primary gaze with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Visual Acuity</condition>
  <arm_group>
    <arm_group_label>senofilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The lenses will be worn for 2 hours in both eyes, and not dispensed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lotrafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The lenses will be worn for 2 hours in both eyes, and not dispensed</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>senofilcon A</intervention_name>
    <description>A soft spherical contact lens</description>
    <arm_group_label>senofilcon A</arm_group_label>
    <arm_group_label>lotrafilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>lotrafilcon B</intervention_name>
    <arm_group_label>senofilcon A</arm_group_label>
    <arm_group_label>lotrafilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy males or females that are at least 18 to no more than 40 years of age.

          2. The subject must read, understand, and sign the Statement of Informed Consent and
             receive a fully executed copy of the form.

          3. The subject must appear able and willing to adhere to the instructions set forth in
             this clinical protocol.

          4. The subject must possess a wearable pair of spectacles with distance vision correction
             which provide satisfactory vision.

          5. The subject is a current spherical soft contact lens wearer (defined as a minimum of 6
             hours of lens wear per week for a minimum of 1 month prior to the study) or has
             sufficient prior experience with soft contact lens wear (defined as a minimum of 30
             days of lens wear during the last 5 years).

          6. The subject's vertexed best sphere distance refraction must be between -0.75 and -5.00
             D in both eyes.

          7. Cylinder refraction less than or equal to -0.75 D in both eyes (any axis).

          8. The subject must have corrected visual acuity of 20/20 or better in each eye.

        Exclusion Criteria:

          1. Currently pregnant or lactating (subjects who become pregnant during the study will be
             discontinued).

          2. Any ocular or systemic allergies or diseases that may interfere with contact lens
             wear.

          3. Any systemic disease, autoimmune disease, or use of medication, which may interfere
             with contact lens wear.

          4. Any known hypersensitivity or allergic reaction to contact lens solutions or sodium
             fluorescein dye.

          5. Any previous ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, etc.)

          6. Current wearers of rigid or hybrid contact lenses.

          7. Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of
             recurrent corneal erosions, aphakia, or moderate or above corneal distortion by
             keratometry.

          8. Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease
             (e.g. HIV).

          9. History of binocular vision abnormality or strabismus.

         10. Employee of the investigational clinic (e.g. Investigator, Coordinator, Technician).

         11. Clinically significant (grade 3 or 4) corneal edema, pterygium, corneal
             vascularization, corneal staining, or any other abnormalities of the cornea or
             conjunctiva which may interfere with the study measurements.

         12. Strabismus, suppression or amblyopia.

         13. Any ocular infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Kelvin Grove</city>
        <state>Queensland</state>
        <zip>4059</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2015</study_first_submitted>
  <study_first_submitted_qc>January 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2015</study_first_posted>
  <results_first_submitted>November 27, 2016</results_first_submitted>
  <results_first_submitted_qc>November 27, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 20, 2017</results_first_posted>
  <last_update_submitted>November 27, 2016</last_update_submitted>
  <last_update_submitted_qc>November 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>A total of 25 subjects were enrolled into this study. Of the enrolled subjects 4 did not meet the eligibility criteria and 21 were dispensed study lenses. Of the dispensed subjects all 21 completed the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Senofilcon A/Lotrafilcon B</title>
          <description>Subjects that were randomized to receive the senofilcon A lens first and then to receive the lotrafilcon B lens.</description>
        </group>
        <group group_id="P2">
          <title>Lotrafilcon B/Senofilcon A</title>
          <description>Subjects that were randomized to receive the lotrafilcon B lens first and then to receive the senofilcon A lens.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All subjects that were dispensed at least 1 study lens throughout the duration of the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Dispensed</title>
          <description>All subjects that were dispensed at least 1 study lens during the course of the study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.1" spread="5.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Natural Blinking</title>
        <description>Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with natural blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.</description>
        <time_frame>2 hours post insertion</time_frame>
        <population>All subjects that have completed all study visits.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A</title>
            <description>Subjects that wore the senofilcon A lens in either the 1st or 2nd period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>Subject that wore the lotrafilcon B in either the 1st or 2nd period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Natural Blinking</title>
          <description>Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with natural blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.</description>
          <population>All subjects that have completed all study visits.</population>
          <units>microns</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.159" spread="0.0662"/>
                    <measurement group_id="O2" value="0.142" spread="0.0605"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Controlled Blink</title>
        <description>Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.</description>
        <time_frame>2 hours post insertion</time_frame>
        <population>All subjects that have completed all study visits.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A</title>
            <description>Subjects that wore the senofilcon A lens in either the 1st or 2nd period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>Subject that wore the lotrafilcon B in either the 1st or 2nd period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Controlled Blink</title>
          <description>Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.</description>
          <population>All subjects that have completed all study visits.</population>
          <units>microns</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.165" spread="0.0857"/>
                    <measurement group_id="O2" value="0.146" spread="0.0567"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Higher Order Root Mean Square (HO RMS) - Distance Target in Primary Gaze With Controlled Blink</title>
        <description>Wavefront metric measured by COAS wavefront sensor while subject fixates a distant target in primary gaze with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.</description>
        <time_frame>2 hours post insertion</time_frame>
        <population>All subjects that have completed all study visits.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A</title>
            <description>Subjects that wore the senofilcon A lens in either the 1st or 2nd period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>Subject that wore the lotrafilcon B in either the 1st or 2nd period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Higher Order Root Mean Square (HO RMS) - Distance Target in Primary Gaze With Controlled Blink</title>
          <description>Wavefront metric measured by COAS wavefront sensor while subject fixates a distant target in primary gaze with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.</description>
          <population>All subjects that have completed all study visits.</population>
          <units>microns</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.125" spread="0.0559"/>
                    <measurement group_id="O2" value="0.132" spread="0.0511"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Throughout the duration of the study. Approximately 1-week per subject.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Senofilcon A</title>
          <description>Subjects that wore the senofilcon A lens in either the 1st or 2nd period of the study.</description>
        </group>
        <group group_id="E2">
          <title>Lotrafilcon B</title>
          <description>Subject that wore the lotrafilcon B in either the 1st or 2nd period of the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST</name_or_title>
      <organization>Johnson &amp; Johnson Vision Care Inc.</organization>
      <phone>904-443-3449</phone>
      <email>CColesb@ITS.JNJ.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

